Sinophobic Growth in Oestrogen Receptor-Negative Metastatic Breast Cancer

Oncology ◽

10.1159/000225735 ◽

1983 ◽

Vol 40 (4) ◽

pp. 241-243 ◽

Author(s):

F. Hartveit ◽

T. Thorsen ◽

M. Tangen ◽

B.O. Mœhle ◽

S. Thoresen ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Oestrogen Receptor ◽

Metastatic Breast

Download Full-text

Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain

European Journal of Cancer ◽

10.1016/j.ejca.2013.07.008 ◽

2013 ◽

Vol 49 (17) ◽

pp. 3694-3707 ◽

Author(s):

A. Guilbert ◽

M. Gautier ◽

I. Dhennin-Duthille ◽

P. Rybarczyk ◽

J. Sahni ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Oestrogen Receptor ◽

Breast Cancer Cells ◽

Transient Receptor Potential ◽

Metastatic Breast ◽

Receptor Potential ◽

Kinase Domain ◽

Transient Receptor Potential Melastatin ◽

Transient Receptor

Download Full-text

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(16)00106-6 ◽

2016 ◽

Vol 17 (6) ◽

pp. 811-821 ◽

Author(s):

Ian E Krop ◽

Ingrid A Mayer ◽

Vinod Ganju ◽

Maura Dickler ◽

Stephen Johnston ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Oestrogen Receptor ◽

Metastatic Breast ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2009.07.015 ◽

2009 ◽

Vol 45 (17) ◽

pp. 2940-2946 ◽

Author(s):

Xavier B. Pivot ◽

Rubi K. Li ◽

Eva S. Thomas ◽

Hyun-Cheol Chung ◽

Luis E. Fein ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Oestrogen Receptor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Epidermal Growth

Download Full-text

Retrospective Study of the Use of Everolimus/Exemestane in the Treatment of Oestrogen Receptor Positive (ER+) Metastatic Breast Cancer (MBC): The Kent Oncology Network Experience

Clinical Oncology ◽

10.1016/j.clon.2015.01.014 ◽

2015 ◽

Vol 27 (6) ◽

pp. e10

Author(s):

J.E. Ang ◽

R. Jyothirmayi ◽

N. Mithal ◽

C. Abson ◽

R. Burcombe ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Retrospective Study ◽

Oestrogen Receptor ◽

Metastatic Breast

Download Full-text

Abstract OT1-03-03: FINESSE - An open, 3-cohort, phase II trial testing oral administration of lucitanib in patients with FGFR1-amplified or non-amplIfied oestrogeN rEceptor poSitive metaStatic breast cancEr

10.1158/1538-7445.sabcs15-ot1-03-03 ◽

2016 ◽

Author(s):

F Andre ◽

F Daly ◽

HA Azim ◽

V Agrapart ◽

D Fumagalli ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Oral Administration ◽

Phase Ii ◽

Oestrogen Receptor ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Download Full-text

ANZ1001 SORBET: Study of Oestrogen Receptor Beta and Efficacy of Tamoxifen—A single-arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps126 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS126-TPS126

Author(s):

B. E. Kiely ◽

K. Phillips ◽

P. A. Francis ◽

F. M. Boyle ◽

J. F. Forbes ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Oestrogen Receptor ◽

Triple Negative ◽

Phase Ii Study ◽

Estrogen Receptor Beta ◽

Metastatic Breast ◽

Download Full-text

Expanding Treatment Arsenal for Oestrogen Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

Hong Kong Journal of Radiology ◽

10.12809/hkjr1916852 ◽

2019 ◽

Vol 22 (2) ◽

pp. 86-97

Author(s):

Henry Sze

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Oestrogen Receptor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Human Epidermal Growth Factor ◽

Epidermal Growth

Download Full-text

Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion

British Journal of Cancer ◽

10.1038/bjc.2016.66 ◽

2016 ◽

Vol 114 (9) ◽

pp. 1019-1026 ◽

Author(s):

Simon A Fry ◽

Claire E Robertson ◽

Ruth Swann ◽

Miriam V Dwek

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Vascular Invasion ◽

Oestrogen Receptor ◽

Metastatic Breast ◽

Download Full-text

SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with oestrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with PIK3CA-mutant tumours

Annals of Oncology ◽

10.1093/annonc/mdw365.92 ◽

2016 ◽

Vol 27 ◽

pp. vi99 ◽

Author(s):

J. Baselga ◽

J. Cortes Castan ◽

M. De Laurentiis ◽

V. Dieras ◽

N. Harbeck ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Oestrogen Receptor ◽

Locally Advanced ◽

Metastatic Breast ◽

Pi3k Inhibitor ◽

Phase Iii ◽

Er Positive ◽

Phase Iii Study

Download Full-text

Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: Results of an exploratory analysis

10.1016/j.breast.2013.08.016 ◽

2013 ◽

Vol 22 (6) ◽

pp. 1087-1093 ◽

Author(s):

S. Glück ◽

C. Russell ◽

J. O'Shaughnessy ◽

E.F. McKenna ◽

S. Hu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Treatment Effect ◽

Oestrogen Receptor ◽

Metastatic Breast ◽

Exploratory Analysis ◽

Oestrogen Receptor Status ◽

Receptor Status

Download Full-text